NCT04491461 is a NA clinical trial of Herbal tea blend in Active Immune Response, sponsored by Natural Immune Systems Inc.

Who is sponsoring NCT04491461?

NCT04491461 is sponsored by Natural Immune Systems Inc.

What drugs are being tested in NCT04491461?

Interventions in NCT04491461: Herbal tea blend, Warm water.

What condition does NCT04491461 study?

NCT04491461 studies Active Immune Response.

Is NCT04491461 still recruiting?

NCT04491461 is currently completed. Last updated 27 September 2022.

Last reviewed 2022-09-27 · How we verify

NCT04491461

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Effects of an Herbal Tea on Immune Surveillance and Activation.

Completed NA Last updated 27 September 2022

What this trial tests

NA trial testing Herbal tea blend in Active Immune Response in 12 participants. Completed in 19 December 2021.

Timeline

27 July 2020

Primary endpoint
25 October 2021

19 December 2021

Quick facts

Lead sponsor	Natural Immune Systems Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	12
Start date	27 July 2020
Primary completion	25 October 2021
Estimated completion	19 December 2021
Sites	1 location across United States

Drugs / interventions tested

Herbal tea blend
Warm water

Conditions studied

Active Immune Response — all drugs for Active Immune Response →

Sponsor

Natural Immune Systems Inc

Who can join

Adults 18 to 75, any sex, with Active Immune Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A small cross-over trial on 24 people involving an herbal tea blend to test whether consuming 1 cup of tea triggers changes in the numbers of natural killer cells in the blood circulation as evidence of immune cell trafficking within 2 hours.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Natural Immune Systems Inc trials

Trials by the same sponsor.

NCT07206407 — Clinical Trial on Rapid Immune Modulating Effects · NA · recruiting
NCT07127705 — Rapid Response of Stem Cells and Immune Cells for Efficacy · NA · recruiting
NCT06754228 — Acute Immune Modulation by Probiotic Strain · NA · recruiting
NCT07142720 — Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity · NA · completed
NCT05176678 — Immunological Effect of Increasing Doses of Natural Peptide · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04491461 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Natural Immune Systems Inc
Last refreshed: 27 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04491461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing